Breast Cancer and Kinesiophobia and Physical Activity
- Conditions
- Breast CancerKinesiophobia
- Interventions
- Other: None intervention
- Registration Number
- NCT05090098
- Lead Sponsor
- Acibadem University
- Brief Summary
Breast cancer is the most common type of cancer in women worldwide. A significant number of breast cancer survivors develop many complications. Breast cancer and survivors may develop a fear of physical activity avoidance and movement, called kinesiophobia, due to upper extremity pain, numbness, restricted arm/shoulder range of motion, and risk of lymphedema. Therefore, in the present study, it is aimed to compare the effect of fear of movement on physical activity, quality of life and psychological states in women who have had breast cancer with healthy people.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 180
-
• Women diagnosed with stage I-II-III breast cancer with surgery as the first treatment
- The patient whose first treatment was completed at least three months ago (surgery, radiotherapy and / or chemotherapy)
- 18-75 years old woman
- Does not have a Turkish literacy problem
-
• A serious chronic disease (rheumatoid arthritis, multiple sclerosis, amyotrophic lateral sclerosis, kidney disease, heart failure, neurological disorders or diabetes mellitus type I or II patients)
- Having severe musculoskeletal pain or disease
- Serious psychiatric illness
- Patients with current cancer attack or metastasis
- Persons with cognitive impairment
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Breast cancer survivors None intervention Sixty patients with grade I-II-III breast cancer, whose primary treatment (surgery, radiotherapy and/or chemotherapy) was completed at least three months ago, who applied to the Hospital Breast Unit clinic, will be included in the study. Patients with problems in reading and writing in Turkish, poor cognitive functions and a serious chronic disease, musculoskeletal pain or disease, severe psychiatric illness, current cancer attack or metastasis will be excluded from the study Healthy people None intervention healthy individuals matched for age and gender will also be included in the study. Breast cancer None intervention Sixty patients with grade I-II-III breast cancer, whose primary treatment (surgery, radiotherapy and/or chemotherapy) is continuing, who applied to the Hospital Breast Unit clinic, will be included in the study. Patients with problems in reading and writing in Turkish, poor cognitive functions and a serious chronic disease, musculoskeletal pain or disease, severe psychiatric illness, current cancer attack or metastasis will be excluded from the study
- Primary Outcome Measures
Name Time Method Questionnaire on exercise barriers Six month This questionnaire contains a total of 35 obstacles. These obstacles are; symptom-related (n = 10), individual (n = 10), psychosocial (n = 8) and environmental (n = 7) factors. You will be asked if these obstacles prevent you from exercising.
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRES (IPAQ) Six month Physical activity level measured in Metabolic Equivalent
Tampa Kinesiophobia Scale Six month The TAMPA Kinesiophobia Scale consists of 17 questions. Each question is scored between 1-4. The maximum score is 68, with high scores indicating an increased severity of kinesiophobia. A score of more than 37 indicates high severity of kinesiophobia.
- Secondary Outcome Measures
Name Time Method Fatigue Severity Scale Six month This scale consists of nine items. Each item is scored between 1 and 7, and as the total score decreases, fatigue decreases.
Hospital Anxiety and Depression Scale Six month The lowest score that patients can get from both subscales is 0, and the highest score is 21. A high score indicates high anxiety and depression values.
Evaluation of Quality of Life: EORTC-Quality of Life -C 30 Six month High scores indicate a high quality of life, and low scores indicate a decreased quality of life.
Trial Locations
- Locations (1)
Acıbadem University
🇹🇷İstanbul, Turkey